Search

Your search keyword '"Takehara, Kazuhiro"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Takehara, Kazuhiro" Remove constraint Author: "Takehara, Kazuhiro" Language english Remove constraint Language: english
242 results on '"Takehara, Kazuhiro"'

Search Results

1. Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study

3. Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

6. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group

9. Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.

11. Uterine serous carcinoma

12. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

18. The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)

19. Analysis of gastric-type mucinous carcinoma of the uterine cervix — An aggressive tumor with a poor prognosis: A multi-institutional study

22. Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.

24. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

26. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)

30. Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial.

31. Intraperitoneal Carboplatin for Ovarian Cancer - A Phase 2/3 Trial.

37. Saturday, July 13, 202410:30 AM - 11:30 AM GPP01 Presentation Time: 10:30 AM: A Phase 3 Study of Pembrolizumab (Pembro) + Chemoradiotherapy (CCRT) for High-Risk Locally Advanced Cervical Cancer (LACC)

38. Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group).

39. Endometrial carcinosarcoma.

42. A Patient with Transverse Colon Cancer Complicated by Cowden Syndrome Administered FOLFOXIRI + Bevacizumab Therapy.

43. Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group

44. Neoadjuvant Chemotherapy of Docetaxel and Carboplatin followed by Radical Hysterectomy could be Promising Treatment in Patients with Stage Ib2 to IIb usual-type Adenocarcinoma: Updated Result of an Advance Study of SGSG-005.: YGA O 04

46. Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.

47. Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE‐775.

48. Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.

Catalog

Books, media, physical & digital resources